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Abstract: Two women with breast carcinoma developed clinical evidence of a sphenocavernous 
syndrome with magnetic resonance (MRI) that suggested a basal skull meningioma but in whom 
biopsy of the lesion revealed metastatic breast carcinoma. The difﬁ  culties in distinguishing 
between the two lesions on the basis of standard MRI are discussed, as are newer imaging 
techniques that may reduce or eliminate these problems.
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Although meningiomas have well-known clinical and imaging features, metastases 
from a variety of different neoplasms such as prostate (Fink 1979; Lippman et al 1986; 
Franco et al 1999), breast (Shapiro and Janzen 1959), lung (Khalfallah et al 1999), 
kidney (Killebrew et al 1983), gall bladder (Kawamata et al 1999), colon (Neroni et al 
1999), and adenoid cystic carcinoma (Morioka et al 1993), as well as leiomyosarcoma 
(Buff et al 1991), can simulate them. In particular, although it often involves bone, 
metastatic breast adenocarcinoma can present as an isolated dural lesion without 
apparent involvement of adjacent bone (Johnson et al 2002). Indeed, Tsukada and 
colleagues (1983) found solitary metastases to the dura in breast cancer in approxi-
mately 8% of autopsied patients. We describe two patients with pathologically proven 
adenocarcinoma of the breast, one of whom developed a cavernous sinus syndrome and 
the other, an orbital apex syndrome, in whom standard magnetic resonance imaging 
(MRI) showed a lesion of the skull base consistent with a basal skull meningioma. In 
each case, the correct diagnosis of a soft-tissue, skull-base metastasis was not made 
until the lesion was biopsied.
Cases
Case 1
A 48-year-old woman developed adenocarcinoma of the breast treated with lumpectomy 
and radiation therapy. Three years later, she developed painless vertical diplopia and 
was found to have a right trochlear nerve paresis. MRI revealed an enhancing, right 
paraclinoid lesion and a smaller, similar lesion on the left (Figure 1). An evaluation 
revealed no evidence of metastases, and it was thought that the patient had a basal skull 
meningioma; however, she then developed increasing oblique diplopia and right ptosis 
and was found to have a right oculomotor nerve paresis. Repeat MRI showed an increase 
in the size and extent of the right-sided lesion with no change in the appearance of the 
lesion on the left. The patient underwent biopsy of the lesion that revealed ﬁ  ndings con-
sistent with metastatic carcinoma of the breast (Figure 2). She subsequently underwent 
whole-brain fractionated radiation therapy combined with stereotactic radiosurgery to Clinical Ophthalmology 2007:1(3) 344
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the anterior skull base in the region of the lesion, followed by 
chemotherapy. Over the next several months, the trochlear 
nerve paresis resolved, and the oculomotor nerve paresis 
improved but did not resolve. The patient died 22-months 
after diagnosis from the effects of metastatic disease.
Case 2
A 56-year-old woman was found to have adenocarcinoma 
of the breast at which time she was also found to have 
changes on computed tomographic scanning consistent with 
Figure 1 Case 1. Initial T1-weighted, axial MRI after intravenous injection of 
paramagnetic contrast material shows enhancing lesions surrounding the anterior 
clinoid processes (arrowheads). The right lesion is larger than the right and may be 
extending through the superior orbital ﬁ  ssure.
Figure 2 Case 1. Pathologic appearance of biopsy specimen. Note nests and cords 
of cancer cells (Hematoxylin and Eosin, X200).
bony metastases to the vertebrae. She underwent a radical 
mastectomy and then began chemotherapy, but shortly 
thereafter, she developed headache and blurred vision in the 
inferior ﬁ  eld of the right eye. Neuro-ophthalmologic exami-
nation showed evidence of an isolated, right retrobulbar optic 
neuropathy characterized by visual acuity of 20/40 in the eye 
associated with color vision of 3/10 using Hardy-Rand-Rittler 
pseudoisochromatic plates, an inferior ﬁ  eld defect, and a rela-
tive afferent pupillary defect. Ophthalmoscopic examination 
of the ocular fundi revealed no abnormalities.
The patient underwent MRI that showed an enhancing 
soft-tissue lesion at the apex of the right orbit extending 
through the superior orbital ﬁ  ssure onto the medial sphenoid 
wing and around the temporal lobe tip (Figure 3). There was 
no involvement of adjacent bone. The differential diagnosis 
was metastatic carcinoma versus sphenoid wing meningioma. 
The patient refused biopsy of the lesion but agreed to undergo 
radiation therapy. The lesion was subsequently treated with 
conventional fractionated radiation totaling 30 Gy.
Shortly after completing radiation therapy, the patient 
experienced improvement in visual sensory function, and 
this was taken as evidence that the lesion was a meningioma, 
particularly as it did not decrease in size or disappear on MRI 
as might be expected if it were a metastasis. Three months 
later, however, she developed recurrent, progressive loss of 
vision in the right eye and a right oculomotor nerve paresis. 
After repeat MRI showed an increase in the size of the mass, 
the patient underwent biopsy and subtotal resection of the 
mass, histopathologic examination of which was found to 
be consistent with metastatic adenocarcinoma (Figure 4). 
She was treated with further radiation therapy as well as 
chemotherapy but died 6-months later.
Discussion
Many patients with orbital or central nervous system (CNS) 
metastases from adenocarcinoma of the breast either have 
or soon develop other manifestations of disseminated dis-
ease. The diagnosis of CNS metastasis usually is made by a 
variety of tests, including serum assay for carcinoembryonic 
antigen (CEA); bone scan; positron emission tomographic 
(PET) scanning; MRI of the brain, spine, or both; lumbar 
puncture; and computed tomographic (CT) scanning or 
MRI of the chest, abdomen, and pelvis. When evidence 
of disseminated disease is absent, as in our ﬁ  rst patient, 
the likelihood of a solitary, enhancing, soft-tissue lesion 
of the skull base being a meningioma is much greater than 
the likelihood that it is an isolated metastasis; however, 
even when evidence of disseminated disease is present, as Clinical Ophthalmology 2007:1(3) 345
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in our second patient, it may be impossible to differentiate 
a metastasis from a meningioma using conventional MRI 
(Johnson et al 2002).
Meningiomas have typical imaging features. They gener-
ally appear as an extra-axial mass with a broad attachment to 
the dura that is hyperdense on CT scanning and that enhances 
after intravenous injection of iodinated contrast material. 
On MRI, the lesion usually is isointense with gray matter on 
T1-weighted images, more variable on T2-weighted images, and 
homogeneously enhancing on T1-weighted images following 
intravenous administration of gadolinium-DTPA (Buetow et al 
1991; Sheporaitis et al 1992) (Figure 5). Dural metastases gener-
ally present in one of two ways: as a subdural hematoma or as 
a tumor mass. It is the latter presentation that can be difﬁ  cult to 
differentiate from a meningioma (Rumana et al 1998; Khalfallah 
et al 1999). Twenty-nine cases of dural metastases interpreted as 
meningioma have previously been reported (Tagle et al 2002). 
Typically, these tumors produce MR images characterized by 
an increased signal on T2-weighted images and an enhancing 
dural tail on T1-weighted images after intravenous injection of 
gadolinium (Quint and McGillicuddy 1994). The enhancement 
of the meninges adjacent to a meningioma on MRI, also seen 
with CT scanning, was once considered speciﬁ  c for meningioma 
(Goldsher et al 1990; Nakau et al 1997); however, it is clear that 
Figure 3 Case 2. Initial T1-weighted, axial MRI after intravenous injection of para-
magnetic contrast material shows an enhancing soft-tissue lesion at the apex of the 
right orbit extending through the superior orbital ﬁ  ssure onto the medial sphenoid 
wing and around the temporal lobe tip (arrowhead).
Figure 4 Case 2. Pathologic appearance of biopsy specimen. Note nests and cords 
of cancer cells (Hematoxylin and eosin, X200).
Figure 5 T1-weighted, axial MRIs after intravenous injection of paramagnetic contrast material in two cases of biopsy-proven sphenoid wing meningiomas. (A) Note simi-
larity of enhancing lesion (arrowhead) that surrounds the right anterior clinoid process to the appearance of the lesion in Case 1. (B) Note similarity of enhancing lesion 
that involves the right orbit (small double arrowheads) as well as the medial sphenoid wing around the temporal lobe tip (large single arrowhead) to our Case 2.
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this sign also can be present in patients with meningeal metastases 
(Wilms et al 1991; Quint and McGillicuddy 1994).
Although standard MRI may be unable to differentiate 
between intracranial meningiomas and metastases, it appears 
that dural metastases and meningiomas have different 
perfusion-sensitive characteristics when assessed using 
dynamic perfusion MRI (DPMRI) (Kremer et al 2004), a 
technique that provides information about a tumor’s vascu-
larity that is not obtained using conventional MRI. DPMRI 
has been used not only to differentiate dural metastases 
from meningiomas (Kremer et al 2004) but also to dif-
ferentiate high-grade from low-grade gliomas (Provenzale 
et al 2002), lymphomas from high-grade gliomas (Kremer 
et al 2002; Hartmann et al 2003), and meningiomas from 
neuromas (Maeda et al 1994). The technique is based on the 
measurement of the MR signal intensity using a T2-weighted 
sequence during the ﬁ  rst pass of a bolus of a paramagnetic 
contrast agent. This signal intensity is transiently reduced 
by susceptibility effects due to the ﬁ  rst pass of paramagnetic 
agent through the vasculature (Barbier et al 2001). It provides 
a map of cerebral blood volume (CBV) and allows the calcu-
lation of the relative cerebral blood volume (rCBV), deﬁ  ned 
as the ratio between the CBV in the tumor and the CBV in 
the white matter. In contrast to the high rCBV typical of 
meningiomas, dural metastases show a low rCBV (Kremer 
et al 2004). Thus, this technique appears to be able to dis-
tinguish between these two lesions. Had this technique been 
available for our patients, we might have been able to spare 
them a craniotomy.
Conclusion
Although metastatic breast carcinoma was considered in 
the differential diagnosis of these two cases, it was not until 
exploratory surgery and histopathological study that the 
correct diagnosis could be established. It can be difﬁ  cult 
to distinguish dural metastases from meningiomas using 
standard neuroimaging techniques, but new tools such as 
dynamic susceptibility contrast MR imaging may help make 
this a less difﬁ  cult problem in the future.
Disclosure
Presented as a poster at the 2006 Meeting of the North 
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